🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Adolescents and Young Adults With Cancer

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797Phase 270 sites📍 Beverly Hills📍 San Francisco📍 Westwood, Los Angeles Fore Biotherapeutics · Tests: Plixorafenib Educational Tools for the Improvement of Early Advance Care Planning in Adolescents and Young Adults With Advanced Solid Tumors and High-Grade Brain Tumors NCT07174661NA1 site📍 Scottsdale Mayo Clinic · Tests: Advance Care Planning, Educational Intervention, Electronic Health Record Review, Survey Administration EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection NCT03266653Phase 28 sites📍 Los Angeles📍 San Francisco📍 Baltimore New York Medical College · Tests: cytotoxic t-lymphocytes Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia NCT03932903NA1 site📍 Chicago Northwestern University · Tests: ADAPTS (ADherence Assessments and Personalized Timely Support). E-CANE: a National Program of Remote Health Education Workshops NCT06748820n/a1 site📍 Nice Centre Hospitalier Universitaire de Nice · Tests: Remote Therapeutic Patient Education (e-TPE) A Study of Questionnaires in Adolescents and Young Adults With Cancer NCT07212166n/a7 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Patient-Reported Outcome Surveys, Spanish version of PRO-AYA and the cognitive interview DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers NCT05770037Phase 2, Phase 327 sites📍 Belfast📍 Birmingham📍 Birmingham Cancer Research UK · Tests: Alectinib DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition NCT05770102Phase 2, Phase 327 sites📍 Belfast📍 Birmingham📍 Birmingham Cancer Research UK · Tests: Atezolizumab A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy) NCT06561074Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Decitabine, Venetoclax, Calaspargase pegol-mknl International Leukemia Target Board NCT05270096n/a7 sites📍 Ghent📍 Copenhagen📍 Budapest Princess Maxima Center for Pediatric Oncology · Tests: Advice Venetoclax Basket Trial for High Risk Hematologic Malignancies NCT05292664Phase 15 sites📍 San Francisco📍 Aurora📍 Atlanta Andrew E. Place, MD · Tests: Venetoclax, Azacitidine, Cytarabine, Methotrexate, Hydrocortisone Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse NCT07871864Phase 377 sites📍 Aarhus📍 Aarhus📍 Copenhagen Gustave Roussy, Cancer Campus, Grand Paris · Tests: Experimental group : Cabometyx ® 40mg/m2/day (Max: 60mg/day) , Treatment schedule : Daily**, day 1-28 during 4 weeks (i… Evaluation of a Psychosocial Support Model for Adolescents and Young Adults Newly Diagnosed With Cancer NCT06979843NA2 sites📍 Gothenburg📍 Stockholm Karolinska Institutet · Tests: A psychosocial model Digital Peer Navigation for Adolescents and Young Adults With Cancer NCT06193369NA1 site📍 Toronto University Health Network, Toronto · Tests: Digital Peer Navigation Outcomes of Health Care Transition for AYA With a Cancer Predisposition NCT07456904n/a1 site📍 Memphis St. Jude Children's Research Hospital · Tests: Readiness Assessment, Transition Outcomes Survey A, Transition Outcomes Survey B A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma. NCT06383338Phase 11 site📍 Melbourne Murdoch Childrens Research Institute · Tests: Omeprazole, Dextromethorphan Pediatric Low Grade Glioma - MEKinhibitor TRIal vs Chemotherapy NCT05180825Phase 225 sites📍 Amiens📍 Angers📍 Besançon University Hospital, Strasbourg, France · Tests: Trametinib, Vinblastine Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention NCT07662239NA3 sites📍 Boston📍 Boston📍 Boston Dana-Farber Cancer Institute · Tests: Exercise Triage and Personalized Exercise Program DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. NCT07440290Phase 2, Phase 327 sites📍 Belfast📍 Birmingham📍 Birmingham Cancer Research UK · Tests: Dabrafenib, Trametinib HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies NCT05658640Phase 1, Phase 236 sites📍 Vienna📍 Ghent📍 Copenhagen Princess Maxima Center for Pediatric Oncology · Tests: Trametinib, Dexamethasone, Cyclophosphamide, Cytarabine, Intrathecal chemotherapy Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma NCT07506239NA1 site📍 San Francisco University of California, San Francisco · Tests: Laser Interstitial Thermal Therapy (LITT), Magnetic resonance imaging (MRI), Questionnaires HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies NCT05751044Phase 1, Phase 233 sites📍 Vienna📍 Ghent📍 Copenhagen Princess Maxima Center for Pediatric Oncology · Tests: Dasatinib, Venetoclax, Dexamethasone, Cyclophosphamide, Cytarabine The Prospective Observational COMPRAYA Cohort Study NCT04682470n/a1 site📍 Amsterdam The Netherlands Cancer Institute · Tests: No intervention ; observational A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer NCT07223463NA4 sites📍 Kansas City📍 New York📍 Cincinnati Children's Hospital Medical Center, Cincinnati · Tests: Tailored Program, Feedback Program (Uniform Standard of Care) Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients NCT07043894Phase 21 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Romiplostim N01 Genomic Profiles Analysis in Children, Adolescents and Young Adult With Sarcomas NCT04621201n/a10 sites📍 Torino📍 Bologna📍 Bologna Azienda Ospedaliera Ospedale Infantile Regina Margherita Sa… · Tests: observation and biopsy PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility Study NCT07874828Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Tirzepatide A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL) NCT06124157Phase 2161 sites📍 Birmingham📍 Phoenix📍 Tucson National Cancer Institute (NCI) · Tests: Biospecimen Collection, Blinatumomab, Bone Marrow Biopsy, Calaspargase Pegol, Cyclophosphamide Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors NCT06625190Phase 1, Phase 21 site📍 Gainesville University of Florida · Tests: Miltenyi CliniMACS Prodigy ® system, Zoledronic acid Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma NCT04972942Phase 116 sites📍 Phoeniz📍 Loma Linda📍 Los Angeles New York Medical College · Tests: Daratumumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy